DapansutrileAlternative Names: OLT-1177
Latest Information Update: 12 Dec 2016
Price : $50
At a glance
- Originator Olatec Industries
- Class Analgesics; Anti-inflammatories
- Mechanism of Action Cytokine modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Musculoskeletal pain
Most Recent Events
- 12 Dec 2016 Chemical structure information added
- 01 Aug 2015 Olatec Industries completes a phase IIb trial for Musculoskeletal pain in USA (NCT02104050)
- 08 Jun 2015 Phase-II development for the treatment of pain associated with osteoarthritis of the knee is ongoing in the US.